Shaun Filliaux

Shaun Filliaux, PhD, is a Medical Writer - Program Lead at Karyopharm Therapeutics Inc. since July 2023, overseeing clinical and regulatory documents for endometrial cancer and myelodysplastic syndromes, and previously led efforts in myelofibrosis while supporting multiple myeloma and other oncology programs. Shaun served as a Graduate Research Assistant at the University of Nebraska Medical Center from January 2019 to May 2024, focusing on chromatin biology and nucleic acid-protein interactions, contributing to multiple publications in this field. Prior experience includes roles as a Scientific Communication Intern at Karyopharm Therapeutics, a Lead Chemist at Marianna Industries ensuring compliance through rigorous analytical testing, and a Quality Control Chemist at Braden Sutphin Ink Company, maintaining product quality and regulatory standards. Shaun holds a PhD in Molecular Biophysics from the University of Nebraska Medical Center and has completed further education at the University of Nebraska at Omaha and the University of Arizona.